Tyco buys radial dilation access company InnerDyne
This article was originally published in Clinica
Executive Summary
Tyco International has enhanced its position in the highly competitive US trocar market with its $180 million purchase of InnerDyne and its radial dilating access devices used in minimally invasive surgery. InnerDyne shareholders will receive a fraction of a Tyco share valued at $7.50 for each of InnerDyne's shares. Both boards have approved the deal.